DE2635476C2 - - Google Patents

Info

Publication number
DE2635476C2
DE2635476C2 DE2635476A DE2635476A DE2635476C2 DE 2635476 C2 DE2635476 C2 DE 2635476C2 DE 2635476 A DE2635476 A DE 2635476A DE 2635476 A DE2635476 A DE 2635476A DE 2635476 C2 DE2635476 C2 DE 2635476C2
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE2635476A
Other versions
DE2635476A1 (de
Inventor
John Sidney Littlehampton Sussex Gb Dowrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEECHAM GROUP Ltd BRENTFORD MIDDLESEX GB
Original Assignee
BEECHAM GROUP Ltd BRENTFORD MIDDLESEX GB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEECHAM GROUP Ltd BRENTFORD MIDDLESEX GB filed Critical BEECHAM GROUP Ltd BRENTFORD MIDDLESEX GB
Publication of DE2635476A1 publication Critical patent/DE2635476A1/de
Application granted granted Critical
Publication of DE2635476C2 publication Critical patent/DE2635476C2/de
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0041Mammary glands, e.g. breasts, udder; Intramammary administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
DE19762635476 1975-08-14 1976-08-06 Tierarzneimittel und verfahren zu ihrer herstellung Granted DE2635476A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB33847/75A GB1547164A (en) 1975-08-14 1975-08-14 Veterinary compositions

Publications (2)

Publication Number Publication Date
DE2635476A1 DE2635476A1 (de) 1977-02-24
DE2635476C2 true DE2635476C2 (de) 1992-08-27

Family

ID=10358231

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762635476 Granted DE2635476A1 (de) 1975-08-14 1976-08-06 Tierarzneimittel und verfahren zu ihrer herstellung

Country Status (16)

Country Link
US (1) US4073920A (de)
JP (1) JPS5225036A (de)
AU (1) AU508341B2 (de)
BE (1) BE844989A (de)
CA (1) CA1070615A (de)
CY (1) CY1063A (de)
DE (1) DE2635476A1 (de)
DK (1) DK151933C (de)
FR (1) FR2320749A1 (de)
GB (1) GB1547164A (de)
HK (1) HK39180A (de)
IE (1) IE43494B1 (de)
KE (1) KE3060A (de)
NL (1) NL185823C (de)
SE (1) SE418246B (de)
ZA (1) ZA764463B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
IL58462A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a penicillin
JPS5568350A (en) * 1978-11-20 1980-05-23 Olympus Optical Co Connector for endoscope
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
GB2119649B (en) * 1982-05-12 1986-02-12 Beecham Group Plc Ophthalmic cloxacillin compositions
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
GB8813670D0 (en) * 1988-06-09 1988-07-13 Beecham Group Plc Veterinary composition
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US7081445B2 (en) * 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
IE970892A1 (en) 1996-12-18 2000-02-09 Bimeda Res And Dev Ltd A veterinary composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
GB0229642D0 (en) 2002-12-20 2003-01-22 Pfizer Ltd Veterinary compositions for treating mastitis
US20040197422A1 (en) * 2002-12-20 2004-10-07 Pfizer Inc Veterinary compositions for treating mastitis
CA2824121C (en) * 2004-02-02 2016-11-22 Bimeda Research & Development Limited Method and device for treating a teat canal of an animal
MX366726B (es) * 2012-02-27 2019-07-22 Bayer New Zealand Ltd Composiciones de liberacion controlada y metodos para su uso.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110875A (en) * 1964-12-11 1968-04-24 Glaxo Lab Ltd Compositions containing procaine penicillins
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
FR2003425A1 (fr) * 1968-03-07 1969-11-07 Unilever Nv Compositions grasses plastiques comestibles et procede pour les preparer
US3826845A (en) * 1969-02-08 1974-07-30 Sankyo Co Ointment base
JPS4891218A (de) * 1972-03-06 1973-11-28
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
CA1052697A (en) * 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals

Also Published As

Publication number Publication date
DK151933B (da) 1988-01-18
GB1547164A (en) 1979-06-06
HK39180A (en) 1980-08-08
DE2635476A1 (de) 1977-02-24
ZA764463B (en) 1977-07-27
IE43494B1 (en) 1981-03-11
CA1070615A (en) 1980-01-29
NL7609013A (nl) 1977-02-16
SE418246B (sv) 1981-05-18
FR2320749A1 (fr) 1977-03-11
DK151933C (da) 1988-06-20
CY1063A (en) 1980-10-24
SE7609055L (sv) 1977-02-15
JPS5225036A (en) 1977-02-24
AU1688076A (en) 1978-02-23
KE3060A (en) 1980-07-11
US4073920A (en) 1978-02-14
DK368276A (da) 1977-02-15
FR2320749B1 (de) 1979-01-12
AU508341B2 (en) 1980-03-20
IE43494L (en) 1977-02-14
NL185823C (nl) 1990-08-01
BE844989A (fr) 1977-02-07
NL185823B (nl) 1990-03-01

Similar Documents

Publication Publication Date Title
JPS5548478B2 (de)
DE2635476C2 (de)
JPS5241714B2 (de)
JPS522591U (de)
JPS5443848Y2 (de)
JPS54801B2 (de)
JPS51106248U (de)
JPS5226788U (de)
JPS5235098Y2 (de)
JPS5619388Y2 (de)
AU493215B1 (de)
JPS5223025U (de)
JPS5210787U (de)
JPS5196717U (de)
JPS51153655U (de)
JPS5283796U (de)
CH592763A5 (de)
BG22563A1 (de)
CH586943A5 (de)
CH587977A5 (de)
CH591693A5 (de)
CH592397A5 (de)
CH592437A5 (de)
BG26465A1 (de)
CH594239A5 (de)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: JUNG, E., DIPL.-CHEM. DR.PHIL. SCHIRDEWAHN, J., DI

D2 Grant after examination
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8305 Restricted maintenance of patent after opposition
D4 Patent maintained restricted